2018 Japan Hepatitis A, B, C, D, E Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests--Blood Banks, Commercial Labs, Hospitals
![](/report_cover/2215/japan-hepatitis-a-b-c-d-e-market-2017-2022_en.gif)
Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.
The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
Contains 241 pages and 14 tables
The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
- Hospitals
- Commercial/Private Labs
- Blood Banks
Contains 241 pages and 14 tables
I. INTRODUCTION
II. HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
CLASSIFICATION
TRANSMISSION OF INFECTION
OCCUPATIONAL HAZARDS
ACUTE HEPATITIS
DIAGNOSIS OF ACUTE INFECTION
CHRONIC HEPATITIS
HCV AND OTHER CHRONIC LIVER DISEASES
ALCOHOLIC LIVER DISEASE
HEPATITIS B COINFECTION
CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
DIAGNOSTIC TESTS
POSSIBLE INDICATIONS FOR HCV RNA TESTING
CONCLUSIONS AND FUTURE DIRECTION
E. Hepatitis D
HISTORICAL PERSPECTIVE
EPIDEMIOLOGY
HBV-HDV 'COINFECTION'VS. 'SUPERINFECTION'
METHODS OF DETECTING HDV
PREVENTION
F. Hepatitis E
BACKGROUND
PREVALENCE OF THE DISEASE
DIAGNOSTIC TESTS
EPIDEMIOLOGIC SEROSURVEYS
SEROLOGIC CROSS-REACTIVITY
G. Hepatitis G
VACCINES AND DRUGS
H. Review of Leading Analyzers Marketed by: Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
I. Emerging Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
II. HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
CLASSIFICATION
TRANSMISSION OF INFECTION
OCCUPATIONAL HAZARDS
ACUTE HEPATITIS
DIAGNOSIS OF ACUTE INFECTION
CHRONIC HEPATITIS
HCV AND OTHER CHRONIC LIVER DISEASES
ALCOHOLIC LIVER DISEASE
HEPATITIS B COINFECTION
CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
DIAGNOSTIC TESTS
POSSIBLE INDICATIONS FOR HCV RNA TESTING
CONCLUSIONS AND FUTURE DIRECTION
E. Hepatitis D
HISTORICAL PERSPECTIVE
EPIDEMIOLOGY
HBV-HDV 'COINFECTION'VS. 'SUPERINFECTION'
METHODS OF DETECTING HDV
PREVENTION
F. Hepatitis E
BACKGROUND
PREVALENCE OF THE DISEASE
DIAGNOSTIC TESTS
EPIDEMIOLOGIC SEROSURVEYS
SEROLOGIC CROSS-REACTIVITY
G. Hepatitis G
VACCINES AND DRUGS
H. Review of Leading Analyzers Marketed by: Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
I. Emerging Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
LIST OF TABLES
Major Companies Developing or Marketing Hepatitis Tests
Japan HAV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
Japan HBV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
Japan HBs Ag Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Hepatitis C Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Anti-HBc Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Anti-HBs Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Anti-HAV Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Hbc Ag Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Hbe Ag Test Volume and Diagnostics Sales Forecast By Market Segment
Japan ALT/SGPT Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Hepatitis Testing Market Diagnostics Sales By Major Supplier
Japan Hepatitis C Testing Market Diagnostics Sales By Major Supplier
Major Companies Developing or Marketing Hepatitis Tests
Japan HAV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
Japan HBV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
Japan HBs Ag Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Hepatitis C Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Anti-HBc Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Anti-HBs Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Anti-HAV Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Hbc Ag Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Hbe Ag Test Volume and Diagnostics Sales Forecast By Market Segment
Japan ALT/SGPT Test Volume and Diagnostics Sales Forecast By Market Segment
Japan Hepatitis Testing Market Diagnostics Sales By Major Supplier
Japan Hepatitis C Testing Market Diagnostics Sales By Major Supplier